$3.77B
$4.11 Million
0.01% of portfolio
161,973
Q2 2025
Reduced 1.2%
$32.7B
$6.57 Million
0.01% of portfolio
75,825
Q2 2025
Added 15.37%
$11.6B
$11.2 Million
0.01% of portfolio
1,257,075
Q2 2025
Reduced 16.92%
$1.9B
$8.75 Million
0.01% of portfolio
330,100
Q1 2025
Reduced 36.2%
$11.6B
$5.74 Million
0.01% of portfolio
381,249
Q2 2025
Added 21.88%
$88.9B
$11.5 Million
0.01% of portfolio
59,083
Q2 2025
Added 14.14%
$8.24B
$4.89 Million
0.01% of portfolio
127,930
Q2 2025
Added 2.82%
$7.56B
$8.04 Million
0.01% of portfolio
113,238
Q2 2025
Added 0.65%
$17.9B
$5.75 Million
0.01% of portfolio
16,473
Q2 2025
Reduced 18.34%
$2.06B
$4.12 Million
0.01% of portfolio
361,084
Q2 2025
Reduced 0.98%
$18.4B
$7.73 Million
0.01% of portfolio
300,800
Q2 2025
Reduced 6.97%
$4.98B
$9.7 Million
0.01% of portfolio
353,997
Q2 2025
Reduced 1.16%
$800M
$9.56 Million
0.01% of portfolio
1,751,037
Q2 2025
Reduced 3.01%
$9.86B
$5.06 Million
0.01% of portfolio
31,904
Q2 2025
Added 0.13%
$14.2B
$8.03 Million
0.01% of portfolio
128,792
Q2 2025
Reduced 0.7%
$7.58B
$7.62 Million
0.01% of portfolio
93,874
Q2 2025
Added 55.34%
$2.27B
$4.59 Million
0.01% of portfolio
135,782
Q2 2025
Added 105.87%
$15B
$10.7 Million
0.01% of portfolio
85,001
Q2 2025
Reduced 18.45%
$42.4B
$6.31 Million
0.01% of portfolio
42,551
Q2 2025
Reduced 11.18%
$21.2B
$5.99 Million
0.01% of portfolio
76,807
Q2 2025
Added 20.32%
5 E Advanced Materials Inc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 28.34%
$4.37B
$2.78 Million
0.0% of portfolio
37,685
Q2 2025
Reduced 85.91%
$0
$3.05 Million
0.0% of portfolio
147,001
Q2 2025
Reduced 11.3%
$3.71B
$3.63 Million
0.0% of portfolio
80,994
Q2 2025
Added 15.22%
$3.82B
$2 Million
0.0% of portfolio
92,648
Q1 2025
Reduced 11.04%
$378M
$522,000
0.0% of portfolio
146,000
Q2 2025
Reduced 15.09%
$1.63B
$2.23 Million
0.0% of portfolio
157,800
Q2 2025
Reduced 0.15%
$7.59B
$1.23 Million
0.0% of portfolio
145,700
Q2 2025
Added 7,326.1%
-
$0
0.0% of portfolio
-
Q2 2025
New
$29.5B
$2.04 Million
0.0% of portfolio
17,401
Q1 2025
Reduced 31.77%
$8.7B
$2.35 Million
0.0% of portfolio
223,522
Q2 2025
Reduced 9.67%
$19.1B
$70,000
0.0% of portfolio
1,021
Q2 2025
New
$8.18B
$2.25 Million
0.0% of portfolio
21,800
Q2 2025
Reduced 48.22%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 32.21%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 59.6%
$2.02B
$2.11 Million
0.0% of portfolio
39,478
Q2 2025
Added 31.59%
$12.9B
$1.29 Million
0.0% of portfolio
48,506
Q2 2025
New
$9.49B
$224,000
0.0% of portfolio
3,590
Q2 2025
Reduced 67.84%
$9.85B
$3.04 Million
0.0% of portfolio
141,144
Q1 2025
Added 2.05%
$1.34B
$1.88 Million
0.0% of portfolio
105,215
Q2 2025
Reduced 4.87%
$1.25B
$184,000
0.0% of portfolio
819
Q4 2024
Reduced 5.32%
$3.79B
$2.25 Million
0.0% of portfolio
392,958
Q2 2025
Added 20.07%
$15.5B
$1.71 Million
0.0% of portfolio
11,863
Q2 2025
Reduced 15.76%
$3.61B
$2.46 Million
0.0% of portfolio
38,411
Q2 2025
Added 1.06%
$8.51B
$2.82 Million
0.0% of portfolio
29,700
Q2 2025
Reduced 27.49%
$163M
$165,000
0.0% of portfolio
146,779
Q4 2022
Reduced 0.4%
Alnylam Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q1 2025
New
$178M
$387,000
0.0% of portfolio
100,000
Q2 2024
Added 124.85%
Amalgamated Financial Corp
-
$0
0.0% of portfolio
-
Q2 2025
Added 1.82%
-
$0
0.0% of portfolio
-
Q2 2025
Added 107.69%